A AB BS ST TR RA AC CT T Cavum septi pellucidi (CSP), cavum vergae (CV) and cavum veli interpositi (CVİ), which are congenital midline brain cysts which are rare, and still have controversial etiologies, developments and treatments. In this paper, it was aimed to introduce the case of detecting CSP cysts and applying medical treatment for the patients who developed loss of consciousness and loss of power in the left limbs, 6 hours after a septoplasty and adenoidectomy. As a result; One should take into account that CSP and CV cysts sometimes could become symptomatic, acute cerebrovascular events could occur during and after the surgical intervention, so that the one should be careful regarding the management of anaesthesia.
ongenital midline brain cysts like cavum septa pellucidi (CSP), cavum vergae (CV) and cavum veli interpositi (CVI) are rare lesions and still have controversial etiologies, developments and treatments. [1] [2] [3] [4] [5] [6] They rarely create significant neurological dysfunctions. These cysts usually carry no clinical importance. 7, 8 Few cases have been reported in the literature that has gone in symptomatic expansion and treated. [1] [2] [3] [4] 6, 9 In this case report, it was aimed to introduce the case of a loss of consciousness and strength in the left extremities, within the 6 th hour following a septoplasty and adenoidectomy operation under general anesthesia and the identification of CSP et vergae with the examinations which is followed by medical treatment.
CASE REPORT
A 22 year old, 60 kg, 162 cm tall female patient, planned for nasal septum deviation and adenoidectomy after she applied to Otolaryngology clinic with her complaints has been diagnosed with nasal septum deviation and adenoid hypertrophy and planned for septoplasty and adenoidectomy operation. No specific feature observed in the preoperative anesthetic evaluation resume. Blood pressure (BP) was 110/70 mmHg and heart rate was measured 75/ min. In the preoperative evaluation of patient, who was identified as American Society of Anesthesiology (ASA)-I, she was induced with thiopental 300 mg, 50 µg fentanyl, 30 mg of rocuronium. In maintenance, 2% sevoflurane, 40% O 2 + 60% dry air mixture continued. Hemodynamic changes during operation remained stable. The surgical procedure was completed in 40 minutes. She was extubated in 42 th minutes when she had enough spontaneous breathing and then she opened her eyes in 43 th minutes and taken into the recovery room. Once delivered to the patient room, within the sixth hour of recovery, because she suffered strength loss in her left upper and lower extremities and as loss of consciousness, she was evaluated by a neurologist and her brain computerized tomography (CT) has been assessed as normal. As symptoms persisted, a diffusion magnetic resonance imaging (MRI) was done and an acute ischemia was detected in the right temporofrontoparietal, she was referred to neurology clinic in the tertiary center. There, with the taken control CT, a hypodense area (ischemic infarction) causing 9 mm of shift to the left in the midline structures, and deletion in the sulci and fissures extending to the right frontotemporoparietal cortex, and also cavum septum pellucidi et vergae variation were observed (Figures 1,2 ). She received 5000 unit bolus of heparin iv and 1000 unit/hr infusion for 12 hour and then continued with low molecular weight heparin and acetylsalicylic acid. She received 4x100 ml mannitol 20% as treatment of anti-edema for 3 days. The patient had normally carotid vertebral doppler ultrasonography and echocardiography. Vasculitis markers (ACA IGG, ACA IGM, ACA IGA, ANCA P, ANCA C, AN-TISM, ds DNA, JO-1, ANTI-LA, ANTI RO) which were examined to explain the etiology were normal. She was discharged on the 10 th day of treatment and physical therapy has been initiated for the loss of strength in the lower and upper extremities. At the clinic control, methylenetetrahydrofolate reductase (MTHFR) gene mutations of patient were negative but plasminogen activator inhibitor-1 (PAI-1) was heterozygous pozitive.
DISCUSSION
CSP was first defined by Franciscus De Le Bon as an abnormal component of the ventricular system and was identified as the 5 th ventricle. CV was first defined by Italian anatomist Vergae in 1851 and was later identified as the 6th ventricle. 5, 9 Cavity wall contains glial fibers, astrocytes and subarachnoid cells. 5, 9 The source of the liquid in the cavity is controversial. Some authors have suggested that these cells arise from residual subarachnoid fluid. There is also no common concept about the naming of this cavity. Some authors use the term "enlarged CSP and CV"; Some others use "CSP and CV cysts". 1, 2, 4, 9, 10 In this report we used the widely used "CSP cyst" term. CSP and CV are in fact the same structures, and they are two cavities, in relationship with a channel called aquaduct septa, one being in the anterior and the other in posterior. 11 While CSP intrauterine was observed in 85-100% in life and in premature, it was observed in adults as 15-20%. 1,9,12 CV incidence in adults is about 1-3% CSP is limited with the genus of the corpus callosum in rostral direction, and columna fornisis in caudal direction.
1,6,10 CV however; is limited with columna fornisis in rostral direction, and with trunkus and splenium of corpus callosum in the caudal direction.
2,7 It's been reported that CSP cyst is seen more often in the literature, and CV cyst is rather less frequent, and usually reported in association with CSP. 1, 4, 8, 11 There are a few isolated cases that have been reported as CVE cysts.
2,5,10 One can detect with an MRI if the cyst is CSP or CV or a combination of both. In the case introduced herein, in the MRI images, it can be seen that the cyst is a CSP with its localization and neighbor-hood. Shaw and Alvord in a study they conducted in an autopsy, have investigated the relationship between ventricular system and CV cysts. 11 The authors reported that they detected two types of CV cyst; 1 communicating (asymptomatic) and 2 noncommunicating (symptomatic) types. At the same time they reported that due to the increase in intracranial pressure and local pressure effects of symptomatic CV cysts, they require surgical treatment. Donati has stated that in such cases, the most common signs and symptoms are headache, vomiting, sensorial and behavioral disorders, and papilledema. 4 In this case, the postoperative clinical assessment has revealed acute impairment of consciousness, and weakness in left arm and leg. CSP and CV cysts which are developmental midline cysts, should be treated when they are symptomatic.
1,2,4,5,7-9 First time, two cases of symptomatic CSP cysts published with anastomosis of cyst and ventricular with transcallosal approach. 5 Treatment methods of these lesions which have been and still being applied are kiston-ventriculostomy with craniotomy, kiston-peritoneal shunt, and stereotactic kiston-shunt applications.
1,6-9,13,14 These methods provide several advantages and disadvantages relative to one another. Medical treatment was applied in the case presented here. The patient in the case was treated with acute ischemia, antiedema and anticoagulant treatments and gained consciousness, and physical therapy has been initiated for the loss of strength in the lower and upper extremities. Another interesting detail in this case is that in the interview done after the surgery, it's been found out that patient's mother also had a stroke incident nearly 15 years ago and there is presence of left hemiplegic sequelae accordingly. There could not be reached any other information about the mother here. In the literature, no information could be found related to CSP or CV that these formations do not cause stroke directly. But as in this case, the idea that the CSP cyst being effected by the intracranial pressure changes during the operation, and this contributing to the formation of a cerebrovascular ischemia and again, the patient's mother having a history of stroke at an early age, could suggest that a genetic coagulation defect. In this case (PAI-1) there was heterozygous pozitive. PAI-1 is a strong inhibitor of fibrinolysis. The human PAI-1 gene is SERPINE 1 and is located on chromosome 7 (7q21.3-q22). The following three genotypes of the PAI-1 are possible; 5G/5G normal, 4G/5G heterozygous, 4G/4G homozygous. Heterozygous form have increased PAI-1 activity and homozygous form have significantly increased PAI-1 activity. 4G/5G polymorphism seems to be a useful marker of fibrinolytic activity and thrombogenic predisposition. Furthermore, there are indications suggesting a significant effects of this genotype on the risk of ischemic stroke in acute stressful diseases through synergy with other procoagulant factors. 15 Although there are some studies about CSP in the literature, there is no study about anesthetic management in the patient with CSP. In this case routine general anesthesia was performed because there was no information about CSP, preoperatively. Although Cavum septi pellucidi et vergae variations are seen as normal congenitally, we think that one should be careful in anesthetic management considering that in some cases it can continue in the form of cysts in adulthood, can be identified with imaging techniques, and especially in the cases with identified family history preoperatively, during and after surgical intervention, acute cerebrovascular incidents might occur.
